D Jeffrey Keyser - Net Worth and Insider Trading
D Jeffrey Keyser Net Worth
The estimated net worth of D Jeffrey Keyser is at least $32,000 dollars as of 2024-12-26. D Jeffrey Keyser is the Director of Lantern Pharma Inc and owns about 10,000 shares of Lantern Pharma Inc (LTRN) stock worth over $32,000. Details can be seen in D Jeffrey Keyser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that D Jeffrey Keyser has not made any transactions after 2020-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of D Jeffrey Keyser
D Jeffrey Keyser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, D Jeffrey Keyser owns 2 companies in total, including Lantern Pharma Inc (LTRN) , and ZS Pharma Inc (ZSPH) .
Click here to see the complete history of D Jeffrey Keyser’s form 4 insider trades.
Insider Ownership Summary of D Jeffrey Keyser
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2020-06-11 | director |
| ZSPH | ZS Pharma Inc | 2015-12-17 | Chief Operating Officer |
D Jeffrey Keyser Latest Holdings Summary
D Jeffrey Keyser currently owns a total of 1 stock. D Jeffrey Keyser owns 10,000 shares of Lantern Pharma Inc (LTRN) as of June 11, 2020, with a value of $32,000.
Latest Holdings of D Jeffrey Keyser
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2020-06-11 | 10,000 | 3.20 | 32,000 |
Holding Weightings of D Jeffrey Keyser
D Jeffrey Keyser Form 4 Trading Tracker
According to the SEC Form 4 filings, D Jeffrey Keyser has made a total of 1 transactions in Lantern Pharma Inc (LTRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lantern Pharma Inc is the acquisition of 10,000 shares on June 11, 2020, which cost D Jeffrey Keyser around $150,000.
Insider Trading History of D Jeffrey Keyser
- 1
D Jeffrey Keyser Trading Performance
GuruFocus tracks the stock performance after each of D Jeffrey Keyser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by D Jeffrey Keyser is 28.7%. GuruFocus also compares D Jeffrey Keyser's trading performance to market benchmark return within the same time period. The performance of stocks bought by D Jeffrey Keyser within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how D Jeffrey Keyser's insider trading performs compared to the benchmark.
Performance of D Jeffrey Keyser
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.12 | | | | | |
| Relative Return to S&P 500(%) | -21.21 | | | | | |
D Jeffrey Keyser Ownership Network
D Jeffrey Keyser Owned Company Details
What does Lantern Pharma Inc do?
Who are the key executives at Lantern Pharma Inc?
D Jeffrey Keyser is the director of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Bios Fund I, Lp , and 10 percent owner Fletcher Aaron G.l. .
Lantern Pharma Inc (LTRN) Insider Trades Summary
Over the past 18 months, D Jeffrey Keyser made no insider transaction in Lantern Pharma Inc (LTRN). Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 378,237 shares made by Bios Fund I, Lp , and a net sale of 378,237 shares made by Leslie W. Kreis .
In summary, during the past 3 months, insiders sold 0 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 756,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 756,474 shares.
Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lantern Pharma Inc Insider Transactions
D Jeffrey Keyser Mailing Address
Above is the net worth, insider trading, and ownership report for D Jeffrey Keyser. You might contact D Jeffrey Keyser via mailing address: 4848 Loop Central Drive, Suite 700, Houston Tx 77081.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
